tiprankstipranks
Trending News
More News >
LFTD Partners (LIFD)
OTHER OTC:LIFD
US Market
Advertisement

LFTD Partners (LIFD) AI Stock Analysis

Compare
16 Followers

Top Page

LIFD

LFTD Partners

(OTC:LIFD)

Rating:44Neutral
Price Target:
$0.50
▲(72.41% Upside)
LFTD Partners faces significant challenges with profitability and bearish technical signals, leading to a low overall score. The negative P/E ratio further suggests valuation concerns. While cash flow improvements are positive, they are overshadowed by operational inefficiencies and bearish market trends.

LFTD Partners (LIFD) vs. SPDR S&P 500 ETF (SPY)

LFTD Partners Business Overview & Revenue Model

Company DescriptionLFTD Partners (LIFD) is a diversified holding company focused on investing in high-growth sectors, including consumer products, technology, and digital marketing. The company aims to leverage its expertise to develop and acquire innovative brands, primarily in the cannabis and lifestyle industries. LFTD Partners is committed to enhancing shareholder value through strategic acquisitions and operational improvements across its portfolio of businesses.
How the Company Makes MoneyLFTD Partners generates revenue through multiple streams, including the sale of consumer products, digital marketing services, and investments in high-growth companies. Key revenue streams include direct sales from its owned brands, online marketing services for third-party clients, and returns from equity investments in its portfolio companies. The company has established significant partnerships within the cannabis sector, allowing it to capitalize on the growing demand for cannabis-related products, while its digital marketing services cater to various industries, providing a steady income from service contracts. Additionally, strategic acquisitions of promising startups contribute to revenue growth and diversification of its income sources.

LFTD Partners Earnings Call Summary

Earnings Call Date:Aug 13, 2025
(Q3-2024)
|
% Change Since: 16.00%|
Next Earnings Date:Nov 12, 2025
Earnings Call Sentiment Negative
The earnings call presented a mixed picture with notable efforts to launch new products and reduce expenses, but these were overshadowed by significant revenue declines, operating losses, and challenges in receivables. The competitive and regulatory environment continues to pose significant challenges to LFTD Partners.
Q3-2024 Updates
Positive Updates
Launch of New Product Line
Launched the newest iteration of the flagship brand, Urb, featuring a Fly High theme with major initiatives to increase direct-to-retailer and direct-to-consumer online sales.
Expense Reduction Achievements
Reduced payroll expenses by 8% from Q1 '24 to Q2 '24 and another 8% from Q2 to Q3 '24. Professional fee expenses down 40% from Q1 to Q2 '24 and another 33% from Q2 to Q3.
Gross Margin Improvement
Excluding the effect of written-off inventory, gross margin as a percentage of net sales improved to 47% compared to 38%.
Negative Updates
Significant Revenue Decline
Consolidated net sales were $8.6 million, down 34% due to regulatory challenges, economic pressure on consumers, and increased competition.
Operating Loss
Reported an operating loss of $141,000 compared to operating income of $659,000 in the previous year.
Net Loss Reported
Net loss was $194,000 or $0.01 per share compared to net income of $617,000 or $0.04 per share.
Challenges in Receivables
Faced $864,000 of bad debt expense due to delayed payments from certain customers, impacting net receivables, net income, and earnings per share.
Company Guidance
During the LFTD Partners' Q3 2024 earnings call, several key metrics and strategic initiatives were discussed to address the current challenges and future prospects of the company. The company's consolidated net sales were reported at $8.6 million, a decline of 34% compared to the previous year, attributed to regulatory challenges and increased competition in the hemp-derived cannabinoid market. Despite these headwinds, the company has been proactive in reducing payroll expenses by 8% from Q1 to Q2 and another 8% from Q2 to Q3, along with a 40% reduction in professional fees from Q1 to Q2 and a further 33% reduction from Q2 to Q3. Furthermore, the company has reduced its CapEx from $747,000 in the previous year to $310,000 year-to-date. The operating loss for the quarter was $141,000, contrasting with an operating income of $659,000 in the same quarter of the previous year. The net loss was reported at $194,000 or $0.01 per share, compared to a net income of $617,000 or $0.04 per share in Q3 2023. The company's current ratio improved to 2.64, reflecting a focus on maintaining financial stability amidst industry challenges.

LFTD Partners Financial Statement Overview

Summary
LFTD Partners shows revenue growth and a strong equity position. However, operational inefficiencies affect profitability, and there is historical cash flow volatility. Improving profit margins and managing liabilities are crucial for better financial health.
Income Statement
45
Neutral
LFTD Partners shows a mixed trajectory in its income statement. While revenue has grown substantially in the TTM period, gross profit margins remain healthy but are offset by negative EBIT and net profit margins, indicating operational inefficiencies and high costs. Revenue growth is a positive indicator, but profitability metrics need improvements for a stronger financial standing.
Balance Sheet
55
Neutral
The balance sheet highlights a strong equity position with a relatively low debt-to-equity ratio, reflecting financial stability. However, there is a substantial increase in total liabilities in the TTM period that could pose risks if not managed. The equity ratio remains healthy, indicating a significant portion of assets financed by equity.
Cash Flow
50
Neutral
Cash flow analysis shows positive free cash flow in the TTM period, a significant improvement from previous years. Operating cash flow covers net income well, suggesting efficient cash management, but the company has experienced fluctuations in free cash flow historically, indicating potential volatility.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue37.33M51.61M57.42M31.66M5.34M
Gross Profit12.75M19.70M20.99M15.94M1.94M
EBITDA-1.50M3.35M10.31M7.40M-1.45M
Net Income-1.86M2.16M7.20M5.80M-1.53M
Balance Sheet
Total Assets47.32M51.35M41.13M39.42M27.83M
Cash, Cash Equivalents and Short-Term Investments2.15M4.36M3.72M1.60M439.08K
Total Debt4.51M4.49M1.86M1.34M3.91M
Total Liabilities9.81M12.53M6.59M11.96M6.21M
Stockholders Equity37.50M38.82M34.54M27.46M21.62M
Cash Flow
Free Cash Flow-1.27M-150.74K2.12M5.25M-408.17K
Operating Cash Flow-960.07K638.92K3.04M5.62M-338.04K
Investing Cash Flow-479.57K-2.52M-916.12K-446.65K-3.51M
Financing Cash Flow-770.95K3.70M-193.42K-4.01M-98.00K

LFTD Partners Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.29
Price Trends
50DMA
0.34
Negative
100DMA
0.35
Negative
200DMA
0.40
Negative
Market Momentum
MACD
-0.01
Positive
RSI
41.26
Neutral
STOCH
93.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LIFD, the sentiment is Negative. The current price of 0.29 is below the 20-day moving average (MA) of 0.31, below the 50-day MA of 0.34, and below the 200-day MA of 0.40, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 41.26 is Neutral, neither overbought nor oversold. The STOCH value of 93.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LIFD.

LFTD Partners Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.46B-0.16-46.00%2.25%22.82%-2.28%
46
Neutral
$8.21M-36.94%2.17%88.34%
44
Neutral
$6.74M-33.13%-7.80%90.17%
44
Neutral
$4.26M-2.05%-21.72%25.00%
41
Neutral
$13.60M-230.73%-24.10%38.17%
39
Underperform
$35.61M-201.88%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
LIFD
LFTD Partners
0.29
-0.55
-65.48%
YCBD
cbdMD
0.76
-3.12
-80.41%
IMCC
IM Cannabis Corp
2.66
-0.29
-9.83%
FLGC
Flora Growth
24.30
-11.99
-33.04%
IXHL
Incannex Healthcare Limited Sponsored ADR
0.38
-1.29
-77.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 23, 2025